Cookies on GOV.UK

We use some essential cookies to make this website work.

We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.

We also use cookies set by other sites to help us deliver content from their services.

You have accepted additional cookies. You can change your cookie settings at any time.

You have rejected additional cookies. You can change your cookie settings at any time.

View cookies

Skip to main content

Navigation menu

Menu

Services and information

Benefits
Births, death, marriages and care
Business and self-employed
Childcare and parenting
Citizenship and living in the UK
Crime, justice and the law
Disabled people
Driving and transport
Education and learning
Employing people
Environment and countryside
Housing and local services
Money and tax
Passports, travel and living abroad
Visas and immigration
Working, jobs and pensions

Government activity

Departments
Departments, agencies and public bodies
News
News stories, speeches, letters and notices
Guidance and regulation
Detailed guidance, regulations and rules
Research and statistics
Reports, analysis and official statistics
Policy papers and consultations
Consultations and strategy
Transparency
Data, Freedom of Information releases and corporate reports

Search

Search GOV.UK

Home
Health and social care
Medicines, medical devices
Vigilance, safety alerts and guidance
Alerts and recalls

Drug Safety Update

From:: Medicines and Healthcare products Regulatory Agency

Alerts, recalls and safety information: medicines and medical devices
Drug Safety Update: monthly PDF newsletter

Search Drug Safety Update

Skip to results

Filter

2 updates

Therapeutic area

Therapeutic area

Anaesthesia and intensive care

Breastfeeding

Cancer

Cardiovascular disease and lipidology

Dentistry

Dermatology

Dispensing GP practices

Ear, nose and throat

Endocrinology, diabetology and metabolism

GI, hepatology and pancreatic disorders

Haematology

Immunology and vaccination

Immunosuppression and transplantation

Infectious disease

Neurology

Nutrition and dietetics

Obstetrics, gynaecology and fertility

Ophthalmology

Paediatrics and neonatology

Pain management and palliation

Pregnancy

Psychiatry

Radiology and imaging

Respiratory disease and allergy

Rheumatology

Urology and nephrology

Published

Published after

For example, 2005 or 21/11/2014

Published before

For example, 2005 or 21/11/2014

2 updates

Go to search results

2 updates

Skip to results

Get emails
Subscribe to feed

2 updates

Metoclopramide: risk of neurological adverse effects

Restricted dose and duration of use.
- Therapeutic area: Anaesthesia and intensive care and 5 others
- Published: 11 December 2014
Letters sent to healthcare professionals since November 2014

Since November 2014, letters were sent regarding vismodegib (Erivedge ▼), chlorhexidine solutions, carbocisteine oral liquid (Mucodyne Paediatric 125mg/5ml), regadenoson (Rapiscan), a parenteral nutrition emulsion (Triomel),…
- Therapeutic area: Anaesthesia and intensive care and 9 others
- Published: 12 February 2015

Get emails
Subscribe to feed

Is this page useful?

Thank you for your feedback

Help us improve GOV.UK

Don’t include personal or financial information like your National Insurance number or credit card details.

This field is for robots only. Please leave blank

What were you doing?

What went wrong?

Help us improve GOV.UK

To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).

Services and information

Benefits
Births, death, marriages and care
Business and self-employed
Childcare and parenting
Citizenship and living in the UK
Crime, justice and the law
Disabled people
Driving and transport
Education and learning
Employing people
Environment and countryside
Housing and local services
Money and tax
Passports, travel and living abroad
Visas and immigration
Working, jobs and pensions

Government activity

Departments
News
Guidance and regulation
Research and statistics
Policy papers and consultations
Transparency
How government works
Get involved

Support links

Help
Privacy
Cookies
Accessibility statement
Contact
Terms and conditions
Rhestr o Wasanaethau Cymraeg
Government Digital Service

All content is available under the Open Government Licence v3.0, except where otherwise stated

© Crown copyright